Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirement) Regulations, 2015, Sharon Bio-Medicine has informed that the following documents are enclosed: Un-audited financial results for the quarter ended June 30, 2021; Limited Review Report for the quarter ended June 30, 2021. The said results are being uploaded on the website of the Company, i.e., www.sharonbio.com. The meeting commenced at 2.00 pm and concluded at 4.15 pm.
The above information is a part of company’s filings submitted to BSE.
